Brevetti EPO No.2706982 2018.01.03
Brevetti EPO
(10) Registration Number and Date
2018000105 2018.03.30
Status
Expired
(180) Expiration Date
(20) Filing Number and Date
SM /T/2018/000105 2012.05.11
(40) Publication Number and Date
SM /T/2018/000105 2018.03.30
(30) Priority Details
EP 11166076
2011.05.13
(71/73) Applicant
(72) Inventor
(IT) OKSCHE, Alexander : c/o Mundipharma GmbHMundipharma Straße 2, 65549 Limburg, DE
(IT) STRANG, John : c/o National Addiction CentreAddiction Sciences Building4 Windsor WalkDenmark Hill, London SE5 8AF, GB
(IT) HARRIS, Stephen : c/o Purdue Pharma L. P.One Stamford Forum201 Tresser Boulevard, StamfordConnecticut 06901-3431, US
(IT) SMITH, Kevin : c/o Mundipharma Research LimitedCambridge Science ParkMilton Road, Cambridge CB4 0GW, GB
(IT) MOTTIER, Lucie Helene Jeanne : c/o Mundipharma Research LimitedCambridge Science ParkMilton Road, Cambridge CB4 0GW, GB
(74) Representative Name
(IT) CATALDI, Silvia : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) FORME POSOLOGICHE FARMACEUTICHE INTRANASALI COMPRENDENTI NALOXONE
(EN) INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE
(57) Abstract
(58) Citations